1.
Pharmacokinetics Study of a Novel Antitumor Drug, Tetrazanbigen;
抗肿瘤新药德氮吡格的药物代谢动力学研究
2.
Proteomics Analysis of Creative New Antitumor Drug of TNBG;
抗肿瘤新药德氮吡格的蛋白质组学研究
3.
A Survey on the Mechanism of a New Antitumor Drug TNBG with Novel Configuration;
创新构型抗肿瘤新药德氮吡格的作用机制探讨
4.
Study on Synthesis of the Intermediate of Antitumor Drug TNBG
抗肿瘤药物德氮吡格中间体ATIQ的合成研究
5.
Study on PPARγ target for novel antitumour drug tetraznbigen
创新抗癌药德氮吡格作用PPAR_γ靶点的研究
6.
Subcellular proteomic analysis of Tetrazanbigen on human hepatocellular carcinoma cell line QGY-7701
德氮吡格对人肝癌细胞QGY-7701的亚细胞蛋白质组学研究
7.
SPE-HPLC determination of tetrazanbigen in mice plasma
固相萃取-高效液相色谱法测定小鼠血浆中德氮吡格
8.
Highly Stereoselective Synthesis of Spiro[cyclopropane-1,4'-pyrazolin-5'-one] Derivertives via Ammonium Ylide
氮叶立德高立体选择性地合成螺[环丙烷-1,4'-吡唑啉-5'-酮]衍生物的研究
9.
4-2-pyridylazo resorcino
４－２－吡啶基偶氮间苯二酚
10.
The basic nitrogen compounds include pyridines and quinolines.
碱性氮化物包括吡啶和喹啉。
11.
Oxidative Aromatization of 1,3,5-Trisubstituted Pyrazolines with Nitric Oxide
一氧化氮氧化芳构化1,3,5-三取代吡唑啉
12.
The Synthesis of 1, 5-Benzothiazepine and Pyrazoline Derivatives Containing Pyrazole;
含吡唑基的1，5-苯并硫氮杂卓及吡唑啉类衍生物的合成
13.
Pharmacokinetics of clopidogrel tablets in beagle dogs
氯吡格雷片比格犬体内的药物动力学
14.
Study on the Complex of Bi(Ⅲ) with PAN
铋(Ⅲ)与1-(2-吡啶偶氮)-2-萘酚配合物的研究
15.
The Crystal Structure of 3,5-di-Br-PADAT
5-[(3,5-二溴-2-吡啶)偶氮]-2,4-二氨基甲苯的晶体结构
16.
A method for determination of sulfasalazine based on fluorescence quenching of CdS nanoparticles
硫化镉纳米粒子荧光淬灭测定柳氮磺吡啶
17.
The Synthesis and QSAR of the Nitrogen Heterocyclic Ring Class Medicine-Sulfinpyrazone;
含氮杂环类药物—磺吡酮的合成及定量构效研究
18.
Charaterization and Pyridine Hydrodenitrogenation Performance of Molybdenum Carbide;
碳化钼的表征和吡啶加氢脱氮性能研究